Richard Page

Q: What Schools Are Affiliated With Richard Page

Richard Page is affiliated with the following schools: Duke University, Harvard University, University of Vermont, McMaster University, University of Wisconsin–Madison, University of Massachusetts Medical School, University of Washington, University of California, San Francisco

Richard Page 's AcademicInfluence.com Rankings

Richard Page

Philosophy

#9920

World Rank

#13549

Historical Rank

Logic

#6873

World Rank

#8430

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Richard Page 's Degrees

Doctorate Medicine Harvard University

Why Is Richard Page Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Richard L. Page is Chair of the Department of Medicine at the University of Wisconsin School of Medicine and Public Health and holds the George R. and Elaine Love Professor endowed Chair. Education Page received his bachelor's and medical degrees from Duke University and the Duke University School of Medicine, followed by residency and specialty training at Massachusetts General Hospital in Boston, Massachusetts. He then completed a fellowship at Duke and joined the Duke faculty.

(See a Problem?)

Richard Page 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography (2006) (3207)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC (2006) (2631)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006) (2558)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (2315)
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie (2007) (1962)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (1569)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (1467)
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. (2013) (1456)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006) (1406)
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007) (1400)
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) (1319)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (1269)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (1197)
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary (2010) (1162)
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation (2007) (1064)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2018) (1054)
Effect of dronedarone on cardiovascular events in atrial fibrillation. (2009) (1047)
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent (2006) (1040)
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (1008)
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang (2006) (1006)
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (927)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (888)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (880)
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. (2008) (872)
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemaker (2008) (866)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (847)
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. (2008) (836)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text (2006) (778)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (709)
Use of automated external defibrillators by a U.S. airline. (2000) (647)
ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults (2010) (636)
Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks (2002) (635)
Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. (1994) (623)
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. (2007) (584)
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. (2008) (563)
Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop (2010) (555)
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (529)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (505)
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (2013) (493)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (426)
[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. (2006) (412)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. (2018) (409)
Hands-only (compression-only) cardiopulmonary resuscitation: a call to action for bystander response to adults who experience out-of-hospital sudden cardiac arrest: a science advisory for the public from the American Heart Association Emergency Cardiovascular Care Committee. (2008) (387)
[ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary]. (2006) (378)
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (372)
ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angi (2008) (369)
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2016) (366)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (321)
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardi (2008) (321)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (317)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (315)
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. (2012) (290)
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. (2013) (287)
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2013) (277)
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2012) (256)
Cardiac Arrest in Pregnancy: A Scientific Statement From the American Heart Association (2015) (250)
Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (2009) (250)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidel (2006) (244)
Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation (2010) (240)
Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. (2002) (236)
Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. (2012) (232)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) (2006) (226)
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2016) (215)
Atrial Reentry around an Anatomic Barrier with a Partially Refractory Excitable Gap: A Canine Model of Atrial Flutter (1986) (213)
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2016) (209)
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. (2009) (204)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (187)
Electrocardiographic Predictors of Arrhythmic Death and Total Mortality in the Multicenter Unsustained Tachycardia Trial (2004) (184)
American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardi (2008) (181)
Biventricular Pacing Decreases Sympathetic Activity Compared With Right Ventricular Pacing in Patients With Depressed Ejection Fraction (2000) (164)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary. (2006) (162)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive summary (2011) (162)
Circus movement in the canine atrium around the tricuspid ring during experimental atrial flutter and during reentry in vitro. (1987) (160)
Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. (2001) (142)
Frequency and Outcome of Arrhythmias Complicating Admission During Pregnancy: Experience From a High‐volume and Ethnically‐diverse Obstetric Service (2008) (134)
Effect of Atrial Fibrillation and an Irregular Ventricular Response on Sympathetic Nerve Activity in Human Subjects (2003) (132)
Treatment of arrhythmias during pregnancy. (1995) (129)
Atypical Right Atrial Flutter Patterns (2001) (124)
Newly Diagnosed Atrial Fibrillation (2004) (121)
Asymptomatic atrial fibrillation. (2005) (116)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (114)
Community approaches to improve resuscitation after out-of-hospital sudden cardiac arrest. (2010) (112)
Effects of repeated electrical defibrillations on cardiac troponin I levels. (1999) (112)
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2016) (111)
Spontaneous Occurrence of Symptomatic Paroxysmal Atrial Fibrillation and Paroxysmal Supraventricular Tachycardia in Untreated Patients (1993) (110)
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. (2009) (110)
Asymptomatic or “Silent” Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide (2003) (108)
Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. (2001) (104)
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association (2016) (102)
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators. (2000) (102)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (101)
Initial energy for elective external cardioversion of persistent atrial fibrillation. (2000) (100)
Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide. (2003) (99)
ACCF / AHA / HRS Focused Update on the Management of atients With Atrial Fibrillation ( Updating the 2006 Guideline ) (2010) (95)
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. (2003) (85)
Rationale and Design of ATHENA: A Placebo‐Controlled, Double‐Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter (2007) (84)
ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis (2008) (83)
Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation. (2001) (81)
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2016) (76)
Treatment of Cardiac Arrhythmias During Pregnancy (1999) (74)
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2016) (68)
Radiofrequency Catheter Ablation of Idiopathic Recurrent Ventricular Tachycardia with Right Bundle Branch Block, Left Axis Morphology (1993) (68)
Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: A systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force (2016) (68)
Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. (1995) (67)
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (66)
Defibrillation aboard a commercial aircraft. (1998) (64)
Dronedarone in patients with congestive heart failure: insights from ATHENA (2010) (63)
Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials. (2013) (63)
Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. (2002) (63)
Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial). (2011) (62)
Serotonin Reuptake Inhibitor (Paxil) Does Not Prevent the Vasovagal Reaction Associated With Carotid Sinus Massage and/or Lower Body Negative Pressure in Healthy Volunteers (2002) (59)
Drug therapy for atrial fibrillation: where do we go from here? (2005) (57)
Ablation of Ventricular Tachycardia Associated with Tetralogy of Fallot: Demonstration of Bidirectional Block (1997) (50)
Antiarrhythmic drugs in pregnancy. (2001) (50)
Clinical practice. Newly diagnosed atrial fibrillation. (2004) (48)
Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force (2016) (47)
Automated External Defibrillators: Technical Considerations and Clinical Promise (2001) (47)
Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular node. (1996) (45)
Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans. (1991) (44)
Baroreflex gain predicts blood pressure recovery during simulated ventricular tachycardia in humans. (1999) (42)
Reflex control of sympathetic activity during simulated ventricular tachycardia in humans. (1999) (41)
Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study (2011) (40)
Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm. (2006) (38)
Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response. (2002) (38)
Biphasic versus monophasic shock waveform for conversion of atrial fibrillation. (2003) (37)
Management of arrhythmia syndromes during pregnancy (2014) (37)
Cardiac arrest at exercise facilities: implications for placement of automated external defibrillators. (2013) (36)
Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. (2010) (34)
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial (2013) (33)
Influence of metoprolol on heart rate variability in survivors of remote myocardial infarction. (1996) (33)
High-frequency ventricular ectopy can increase sympathetic neural activity in humans. (2010) (33)
The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design. (2011) (32)
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease. (2006) (32)
AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy : Executive summary (2011) (32)
Approach to the diagnosis and initial management of the stable adult patient with a wide complex tachycardia. (2008) (31)
Effect of P-Wave Timing During Supraventricular Tachycardia on the Hemodynamic and Sympathetic Neural Response (2001) (31)
Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function. (2000) (30)
Atrioventricular Junction Ablation Followed by Resynchronization Therapy in Patients with Congestive Heart Failure and Atrial Fibrillation (AVERT‐AF) Study Design (2006) (30)
Racial Differences in Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) A Comparison of Whites Versus Blacks (2003) (29)
Effect of radiofrequency ablation on atrial mechanical function in patients with atrial flutter. (1999) (27)
Diagnostic Approach to Narrow Complex Tachycardia with VA Block (1997) (27)
Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation. (2000) (25)
Long‐Term Outcome of Patients with Bifascicular Block and Unexplained Syncope Following Cardiac Pacing (2016) (25)
Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry. (2004) (23)
Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials. (2003) (22)
Initial experience with a high-impedance tined endocardial pacemaker lead: evidence for increased lead failure. (1997) (21)
Antiarrhythmic drugs in pregnancy (2015) (20)
on Practice Guidelines of Cardiology Foundation Foundation/American Heart Association Task Force Atrial Fibrillation (Update on Dabigatran): A Report of the American College 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With (2011) (20)
beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias? (2000) (19)
Percutaneous Coronary Intervention) (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Cardiology/American Heart Association Task Force on Practice Guidelines Intervention—Summary Article: A Report of the American College of ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary (2006) (19)
Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation (2016) (18)
Azimilide for the Treatment of Atrial Fibrillation, Atrial Flutter, and Paroxysmal Supraventricular Tachycardia: Results of a Randomized Trial and Insights on the Concordance of Symptoms and Recurrent Arrhythmias (2008) (17)
Management of ventricular arrhythmias: a trial-based approach. (1999) (17)
Effect of acute amiodarone loading on energy requirements for biphasic ventricular defibrillation. (2001) (17)
Arrhythmias occurring during pregnancy. (2002) (17)
Importance of complete system removal of infected cardioverter-defibrillators. (1995) (17)
Selective radiofrequency ablation of the "slow" atrioventricular nodal pathway for control of the ventricular response to atrial fibrillation. (1996) (17)
Short QT: when does it matter? (2007) (16)
Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society (2011) (16)
Determinants of Nonthoracotomy Biphasic Defihrillation (1997) (15)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention (2008) (15)
Correlation between time-domain measures of heart rate variability and scatterplots in patients with healed myocardial infarcts and the influence of metoprolol. (1997) (15)
Pharmacological therapy of atrial fibrillation (2007) (15)
Medical management of atrial fibrillation: future directions. (2007) (15)
Effects of Prolonged Spaceflight on Atrial Size, Atrial Electrophysiology, and Risk of Atrial Fibrillation (2018) (14)
P‐Wave Amplitude and PR Changes in Patients With Inappropriate Sinus Tachycardia: Findings Supportive of a Central Mechanism (2018) (14)
Wenckebach periodicity at rest that normalizes with tachycardia in a family with a NKX2.5 mutation. (2012) (14)
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death (2008) (14)
merican Heart Association/American College of Cardiology oundation/Heart Rhythm Society Scientific Statement on oninvasive Risk Stratification Techniques for Identifying atients at Risk for Sudden Cardiac Death (2008) (14)
Sympathoexcitation is attenuated during low level lower body negative pressure in subjects who develop pre-syncope (2003) (14)
Public access defibrillation. (2011) (13)
Psychogenic pseudosyncope: Not always a diagnosis of exclusion (2018) (12)
Selective parasympathetic denervation following posteroseptal ablation for either atrioventricular nodal reentrant tachycardia or accessory pathways. (2000) (12)
Abstract 4097: Rhythm- and Rate-Controlling Effects of Dronedarone in Patients with Atrial Fibrillation: Insights From the ATHENA Trial (2008) (12)
The automated external defibrillator: critical link in the chain of survival. (2003) (11)
Another Shock for Sudden Death Prevention after Myocardial Infarction. (2018) (11)
Azimilide dihydrochloride: a new class III anti-arrhythmic agent (2000) (11)
The Role of the Baroreflex in Tilt Table Testing: Outcome and Type of Response. (2016) (11)
Sudden Cardiac Death Prediction and Prevention (2010) (10)
Restoring Sinus Rhythm Improves Baroreflex Function in Patients With Persistent Atrial Fibrillation (2016) (10)
The Right Place at the Right Time: Optimizing Automated External Defibrillator Placement in the Community (2017) (9)
Developed in Collaboration With the European Heart Rhythm Association and the Sudden Cardiac Death) Management of Patients With Ventricular Arrhythmias and the Prevention of Practice Guidelines (Writing Committee to Develop Guidelines for (2007) (9)
Diagnosis of ICD Lead Failure Using Continuous Event Marker Recording (1995) (9)
Clinical Characteristics and Outcome of Patients with Situational Syncope Compared to Patients with Vasovagal Syncope (2017) (9)
Out-of-Hospital Cardiac Arrest--Are Drugs Ever the Answer? (2016) (9)
Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines: Atrial Fibrillation Registry. (2021) (8)
The Effect of Biphasic Defibrillation on the Immediate Pacing Threshold of a Dedicated Bipolar, Steroid‐Eluting Lead (1999) (8)
Latency of ECG Displays of Hospital Telemetry Systems: A Science Advisory From the American Heart Association (2012) (7)
Advances in Resuscitation (2012) (7)
Effects of Azimilide on Heart Rate and ECG Conduction Intervals during Sinus Rhythm in Patients with a History of Atrial Fibrillation (2002) (7)
Evaluation of Outpatients Experiencing Implantable Cardioverter Defibrillator Shocks Associated with Minimal Symptoms (1994) (7)
Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction (2017) (7)
GUIDELINE 2011 ACCF / AHA / HRS Focused Update on the Management of Patients With Atrial Fibrillation ( Updating the 2006 Guideline ) (2010) (6)
The pathophysiologic mechanisms associated with hypotensive susceptibility (2016) (6)
Heart Rate During Spontaneous and Induced Paroxysmal Supraventricular Tachycardia (1995) (6)
Automated external defibrillator use by police responders: where do we go from here? (2002) (6)
To the editor: response---Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine. (2010) (6)
The US Food and Drug Administration Premarket Approval Process and the 515 Program Initiative: View From a Panel Chair. (2016) (6)
A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention (2008) (6)
Antiarrhythmic drugs for all patients with an ICD? (2006) (6)
Intracardiac shunts resulting from transseptal catheterization for ablation of accessory pathways in otherwise normal hearts. (1998) (5)
Effect of biphasic endocardial countershock on pacing thresholds in humans. (1996) (5)
The AED in resuscitation: it's not just about the shock. (2011) (5)
Ventricular arrhythmias in the elderly: evaluation and medical management. (2012) (5)
Bidisomide (SC‐40230), a new antiarrhythmic agent: Initial study of tolerability and pharmacokinetics (1992) (5)
Electrophysiology and autonomic influences of the human atrioventricular node. (1988) (5)
Interaction of a commercial heart rate monitor with implanted pacemakers. (1999) (4)
Guidance for the Heart Rhythm Society pertaining to interactions with industry endorsed by the Heart Rhythm Society on April 26, 2011. (2011) (4)
Pharmacological therapy for atrial fibrillation: current options and new agents. (2009) (4)
Poor baroreflex gain is a marker of heightened sympathetic activity post-tachycardia termination in humans (2003) (4)
Ongoing Management of Patients With Supraventricular Tachycardia. (2016) (4)
The Closing Argument for Surgical Left Atrial Appendage Occlusion. (2021) (4)
Relation of echocardiographic wall motion score index and response to dobutamine stress to defibrillation threshold at the time of implantation of a cardiac defibrillator. (2005) (3)
Public Access Defibrillation. (2009) (3)
The Hot Can: ICD Failure Presenting as Severe Shoulder Pain (2001) (3)
Atrial Fibrillation (Updating the 2006 Guideline) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With (2011) (3)
Asymptomatic atrial fibrillation: problems of management. (2001) (3)
Treatment of supraventricular tachycardias with transcatheter delivery of radiofrequency current. (1992) (3)
Utility of transtelephonic ECG monitoring in evaluating discharges from a third-generation implantable cardioverter defibrillator. (1993) (3)
Early Recurrence of Atrial Fibrillation: (2004) (2)
Heart Rhythm Society Scientific Program Committee (2007) (2)
Arrhythmias in Pregnancy (1999) (2)
Multiuser clinical electrophysiology database using low-cost PCs in a Novell Netware Environment (1992) (2)
Atrial Fibrillation (Update on Dabigatran) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With (2011) (2)
Basic life support (BLS) in adults (2011) (2)
ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults (2009) (2)
Genotype-Phenotpe Correlations in Hypertrophic Cardiomyopathy Insights Provided by Comparisons of Kindreds With Distinct and Identical j3-Myosin Heavy Chain Gene Mutations (2005) (2)
Pharmacological therapy for atrial fibrillation: current options and new agents (2009) (2)
Patients With ST-Elevation Myocardial Infarction : 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of (2012) (2)
Acute Treatment of Patients With Supraventricular Tachycardia. (2016) (2)
Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop Sudden Cardiac Death Prediction and Prevention: Report From a National (2010) (1)
The President's page: the Heart Rhythm Society launches new strategic plan. (2010) (1)
Sudden Cardiac Death Advances in Resuscitation (2012) (1)
Automatic External Cardioverter-Defibrillator Therapy (1998) (1)
New-onset paroxysmal atrial fibrillation: is permanence inevitable? (2005) (1)
The subcutaneous defibrillator: Modest step or quantum leap? (2017) (1)
Fibrillation : ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial (2012) (1)
“Vasovagal” Response during Ventricular Fibrillation: Incidence and Implications (2015) (1)
Use of transesophageal atrial pacing with adenosine infusion to evaluate ventricular preexcitation. (1995) (1)
Arrhythmias During Pregnancy (2002) (1)
Book Review Atrial Fibrillation: From Bench to Bedside (Contemporary Cardiology.) Edited by Andrea Natale and José Jalife. 453 pp., illustrated. Totowa, NJ, Humana Press, 2008. $99.50. 978-1-58829-856-0 (2008) (0)
Pharmacologicaltherapyfor atrialfibrillation:current optionsandnewagents (2009) (0)
Clinical Predictors of Antiarrhythmic Drug Response in the MUSTT Trial (1998) (0)
Cardiac Arrest in Pregnancy (2015) (0)
Cardiac Arrest at Exercise Facilities (0)
Practice Guidelines 2010 Accf/aha Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults a Report of the American College of Cardiology Foundation/american Heart Association Task Force on Practice Guidelines ¶ ¶recused from Voting on Section 2.4.2, Recommendations for Measurement of (0)
Arrhythmias During Pregnancy: Special Considerations (2001) (0)
Biphasic Endocardial Defibrillation Raises the Pacing Threshold in a Steroid-eluting ICD Lead (1998) (0)
Trans-thoracic ventricular defibrillation: from bench to bedside; from ambulance to aircraft aisle (1998) (0)
Automated external defibrillators: Recent developments and lessons from airline and casino experiences (2001) (0)
Flight attendant response to AED instruction: results of a survey and implications for training public access defibrillation (2002) (0)
Efficacy and safety of sustained-release propafemone (propafenone SR) for patients with atrial fibrillation (2004) (0)
The Role of the Barore ﬂ ex in Tilt Table Testing Outcome (2016) (0)
New treatment options for stroke prevention in atrial fibrillation (2005) (0)
Arrhythmias in Pregnancy and Postpartum (2011) (0)
Major Guideline Changes for CRT in the 2012 ACCF/AHA/HRS Focused Update (2012) (0)
Acute Antiarrhythmic Therapy of Ventricular Tachycardia and Ventricular Fibrillation. (2010) (0)
Heart Association Emergency Cardiovascular Care Committee Sudden Cardiac Arrest. A Science Advisory for the Public From the American Action for Bystander Response to Adults Who Experience Out-of-Hospital Hands-Only (Compression-Only) Cardiopulmonary Resuscitation: A Call to (2008) (0)
Absence of prevalence-incidence bias in the antiarrhythmic vs. implantable defibrillator (AVID) trial (1998) (0)
Azimilide reduces symptom burden at the time of arrhythmia recurrence in patients with atrial fibrillation (2002) (0)
THE HEART RATE DURING TILT IS LOWER IN PATIENTS WITH VASOVAGAL SYNCOPE AND POSITIVE TILT TABLE TEST WHEN COMPARED TO PATIENTS WITH VASOVAGAL SYNCOPE AND NEGATIVE TILT TABLE TEST WITH NO SIGNIFICANT CHANGE THE BAROREFLEX (2016) (0)
Mechanisms of sinus node cycle length changes during ventricular fibrillation (2015) (0)
BAROREFLEX GAIN IS ELEVATED IN PATIENTS WITH A POSITIVE TILT TABLE TEST WITH GREATER VALUES NOTED IN PATIENTS WITH TILT-INDUCED ASYSTOLE (2016) (0)

This paper list is powered by the following services:

Other Resources About Richard Page

What Schools Are Affiliated With Richard Page ?

Richard Page is affiliated with the following schools:

Richard Page 's Academic­Influence.com Rankings